The Cancer Health Services Research (CHSR) unit’s mission is to improve value-based cancer services across the care continuum using real-world outcomes and cost data.
The CHSR unit supports the translation of research findings from the laboratory to clinical practice. In doing so, the unit aims to improve cancer services by utilising real-world data to analyse patterns of care provision, including treatment sequencing, and their health economics implications.
The CHSR unit is part of the University of Melbourne Centre for Cancer Research (UMCCR) and the Melbourne School of Population & Global Health (MSPGH) Centre for Health Policy with active collaborations within the Victorian Comprehensive Cancer Centre (VCCC) particularly Western Health and the Peter MacCallum Cancer Centre. The Chair of the CHSR unit also collaborates actively with the University of Twente in the Netherlands on molecular diagnostics in precision medicine.
HEAD OF UNIT
Unit Contact details
Victorian Comprehensive Cancer Centre (VCCC)
Level 13, 305 Grattan Street, Melbourne, Victoria 3000, Australia
The University of Melbourne
Faculty of Medicine, Dentistry and Health Sciences
Melbourne School of Population and Global Health
A new model has conservatively estimated that a three-month delay in cancer diagnosis and treatment due to COVID-19 would result in 90 additional deaths and $12 million in additional healthcare costs in Australia over five years.News
A Victorian and Tasmanian chapter of the Professional Society of Health Economics and Outcomes Research (ISPOR) student network has been launched, fostering the development of future leaders in health economic and outcomes research.News
As part of the University of Melbourne Centre for Cancer Research (UMMCR) seminar series, Dr Koen Degeling gave a presentation about the challenges for estimating health and economic outcomes of oncology care pathways and how real-world data from clinical registries can be used to address these challenges.News
Today, 1 May 2020, we celebrate two-years of activity of the Cancer Health Services Research group, established as one of the strategic research programs in the Victorian Comprehensive Cancer Centre (VCCC). While we pay respect to many colleagues who are committed to work and manage with this difficult COVID-19 period, it is also good to celebrate progress and to share the success of collaboration.News
Some countries have reported a 40 per cent decline in cancer cases at the peak of COVID-19, but an early GP visit means hospitals can prioritise care and capacity for cancer patientsNews
Published in PharmacoEconomics, Dr Koen Degeling, Martin Vu, Professor Maarten IJzerman and collaborators have shared findings of a comprehensive methodological review of health economic evaluations of systemic therapies for metastatic colorectal cancer.News
Traditional clinical trials have been vital for improving cancer treatments for the last 70 years, but new data-driven approaches can enhance treatment for individuals and better allocate healthcare resources for everyoneNews
Precision medicine is taking us from a one-size-fits-all approach to using patient-specific information—including genomics, clinical and administrative data—to guide healthcare decisions tailored to a specific patient. It is driving improved outcomes through access to more effective treatments earlier, therefore reducing economic and health service burdens.News
Prof Maarten IJzerman, Head of Cancer Health Services Research presented at this week's UMCCR Seminar Series at VCCC.News
Whole-genome sequencing is changing the cancer treatment landscape, but we have to understand its use in the real-world to support a more sustainable, affordable health system, writes Prof Maarten Ijzerman in Pursuit.News
Effective cancer services and treatments increasingly depend on high-quality data insights. Professor Maarten IJzerman addresses the challenges at a joint VCCC-MSPGH seminar.News
Professor Maarten J. IJzerman, Chair of Cancer Health Services Research to the Centre for Health Policy.News
The Cancer Health Services Research unit drives a strong data-driven research program that is focussed on improving the delivery of cancer services. The CHSR unit has a common research interest in data-science and data-linkage of different large medical and administrative registries to be able to monitor the care provided to cancer patients across the care continuum. Clinical outcomes and cost analyses using linked data-sets inform the value of our services to patients and help rationalise decisions about improving our services mainly in hospital settings.
The research areas we investigate.View
CANCER HEALTH ECONOMICS
The Cancer HSR unit supports clinical and translational researchers with specific expertise in Health Economics and Data-Driven Health Services Research.View
Our Unit produces consistently high-quality peer reviewed publications.View
Our Unit has produced a range of useful resources that stem from both teaching and research activities.View
The CHSR unit is involved in the online MSc of Cancer Sciences developed by the University of Melbourne and the Victorian Comprehensive Cancer Centre. Topics covered are Cancer Health Services Research and Cancer Health Economics.
The Cancer Health Services Unit has active collaborations in Australia and worldwide. As a member of the Victorian Comprehensive Cancer Centre, the CHSR plays a pivotal role in the development and use of healthcare admin and clinical data for the improvement of cancer health services across Victoria. Most of the work of the CHSR unit is with the leading Victorian hospitals, including Western Health, Peter MacCallum Cancer Centre, the Austin, Royal Melbourne, St. Vincent’s and Royal Women’s hospitals. The CHRS unit has an active research collaboration with the Netherlands Cancer Institute (Amsterdam), the University of Twente and the University Medical Centre in Groningen (all in the Netherlands). The CHSR unit is involved in several other international projects with the Institute for Cancer Research / Royal Marsden in London (UK), the Institut Curie in Paris (France) and the University of Calgary and Toronto (Canada).